1.
Bioorg Med Chem Lett
; 16(21): 5538-41, 2006 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16931004
RESUMO
A series of pyridone-N-benzyl-propanoic acids have been optimised to afford potent orally bioavailable VLA-4 antagonists.